Get startedLog in
    Picture of Shanghai Haohai Biological Technology Co logo

    6826 — Shanghai Haohai Biological Technology Co Income Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Shanghai Haohai Biological Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    CAS
    CAS
    CAS
    CAS
    CAS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue1,3321,7672,1302,6542,698
    Cost of Revenue
    Gross Profit9941,2751,4611,8641,853
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses1,0741,3841,8962,1472,230
    Operating Profit259383234507467
    Gain / Loss on Sale of Assets
    Other Net Non Operating Costs
    Net Income Before Taxes257383236508466
    Provision for Income Taxes
    Net Income After Taxes226347190412376
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income230352180416420
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income230352180416420
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS0.9321.430.8981.741.9
    Dividends per Share